Role of continuous glucose monitoring in the management of glycogen storage disorders
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Management of liver glycogen storage diseases (GSDs) primarily involves maintaining normoglycemia through dietary modifications and regular glucose monitoring. Self‐monitoring of blood glucose is typically done 3–6 times per day, and may not sufficiently capture periods of asymptomatic hypoglycemia, particularly during sleep. Continuous glucose monitoring systems (CGMS) provide 24‐h continuous glucose data and have been used effectively in diabetes mellitus to monitor metabolic control and optimize treatment. This is a relatively new approach in GSDs with only a handful of studies exploring this modality. In this study we used Dexcom CGMS to study the glycemic profile of 14 pediatric and six adult patients with GSD I, III, and IX. A total of 176 days of CGMS data were available. The CGMS was found to be a reliable tool in monitoring glucose levels and trends at all times of the day with good concordance with finger‐stick glucose values. This study revealed that in addition to overnight hypoglycemia, CGMS can uncover previously undetected, subclinical, low glucose levels during daytime hours. Additionally, the CGMS detected daytime and overnight hyperglycemia, an often overlooked concern in liver GSDs. The CGMS with concurrent dietary adjustments made by a metabolic dietitian improved metabolic parameters and stabilized blood glucose levels. The CGMS was found to be a safe, effective, and reliable method for optimizing treatment in patients with GSD I, III, and IX.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 2×
“Trials in diabetic populations have shown its utility in improving glycemic control, as evidenced by reduction in glycosylated hemoglobin (HbA1c) and preventing hypo- and hyperglycemic episodes (Beck et al 2017; Spaic et al 2017; Lind et al 2017; Aleppo et al 2017).”
BackgroundLind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Aleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2482 · Cited by 329 · cited 2×
“Trials in diabetic populations have shown its utility in improving glycemic control, as evidenced by reduction in glycosylated hemoglobin (HbA1c) and preventing hypo- and hyperglycemic episodes (Beck et al 2017; Spaic et al 2017; Lind et al 2017; Aleppo et al 2017).”
BackgroundContinuous glucose monitoring: A review of the technology and clinical use
Klonoff, D. C., Ahn, D., & Drincic, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.005 · Cited by 320 · cited 2×
“In addition, there is also a sensor reaction time for glucose to diffuse into the sensor and sensor signal processing time, all of which contribute to a total lag time of 5–15 min (Klonoff et al 2017).”
BackgroundMethodYoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244 · cited 1×
“For patients, CGMS could play an important role in achieving better glycemic control by improving motivation and preventing burn-out in the long-term (Fonda et al 2016; Allen et al 2008; Yoo et al 2008).”
BackgroundCharleer, S., Mathieu, C., Nobels, F., De Block, C., Radermecker, R. P., Hermans, M. P., Taes, Y., Vercammen, C., T'Sjoen, G., Crenier, L., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02498 · Cited by 196 · cited 1×
“#3 above and established in literature (Charleer et al 2018; Polonsky and Hessler 2013).”
Allen, N. A., Fain, J. A., Braun, B., & Chipkin, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.006 · Cited by 182 · cited 1×
“For patients, CGMS could play an important role in achieving better glycemic control by improving motivation and preventing burn-out in the long-term (Fonda et al 2016; Allen et al 2008; Yoo et al 2008).”
BackgroundThe Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes
Fonda, S. J., Graham, C., Munakata, J., Powers, J. M., Price, D., & Vigersky, R. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816628547 · Cited by 81 · cited 2×
“Cost effectiveness of CGMS is well recognized in T1DM and T2DM patients; it is likely that such economic benefits would accrue to patients with GSDs too (Fonda et al 2016; Huang et al 2010).”
Background
Cited by
Merino, J., Linenberg, I., Bermingham, K. M., Ganesh, S., Bakker, E., Delahanty, L. M., Chan, A. T., Capdevila Pujol, J., Wolf, J., Al Khatib, H., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac026 · Cited by 46
Continuous glucose monitoring for hypoglycaemia in children: perspectives in 2020
Worth, C., Dunne, M., Ghosh, A., Harper, S., & Banerjee, I. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13029 · Cited by 37
“Further studies have since demonstrated improved detection of both hypoglycaemia and hyperglycaemia in patients with GSD I, III and IX.(49) Intermittent use of CGM for glucose profiling in GSD patients is now standard practice in many centres as it provides a more accurate picture of a patient's daily profile than is…”
BackgroundContinuous glucose monitoring for children with hypoglycaemia: Evidence in 2023
Worth, C., Hoskyns, L., Salomon-Estebanez, M., Nutter, P. W., Harper, S., Derks, T. G. J., Beardsall, K., & Banerjee, I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1116864 · Cited by 29
Metadata
- Authors
- Herbert, M., Pendyal, S., Rairikar, M., Halaby, C., Benjamin, R. W., & Kishnani, P. S.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2018-05-25
- Volume
- 41
- Issue
- 6
- Pages
- 917-927
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2804130304
- Cited by
- 42
- References
- 8
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of continuous glucose monitoring in the management of glycogen storage disorders. https://app.cochat.ai/papers/10.1007/s10545-018-0200-5
- The paper
- Herbert, M., Pendyal, S., Rairikar, M., Halaby, C., Benjamin, R. W., & Kishnani, P. S. (2018). Role of continuous glucose monitoring in the management of glycogen storage disorders. Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-018-0200-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.